| Log in

Bionpharma acquires 25 products of Banner Life Sciences

21 December, 2015

Bionpharma, a New Jersey-based pharmaceutical startup founded by former Ranbaxy executives, has bought 25 products from Banner Life Sciences, a division of US-based Patheon, The Economic Times reported.

The acquired products, which include cetirizine and ibuprofen and sold over the counter in the US, together generate revenues of $70 million.

Bionpharma was founded in November 2014 by five senior executives , including CEO Venkat Krishnan, of Ranbaxy Laboratories’ US arm. The company was formed to offer services for Indian and European drug makers seeking to enter the US.

Currently, New York-based global investment firm Signet Healthcare owns more than 40 per cent in Bionpharma. Canadian drugmaker Pharmascience is the second-largest equity holder while the five former Ranbaxy executives form the third-largest group of shareholders. 

The launch of Bionpharma came after India’s top drugmaker Sun Pharmaceutical Industries announced last year that it will acquire Ranbaxy Laboratories. The deal worth $3.2 billion was completed in March 2015.


Leave Your Comment
Sun Pharma to buy Ranbaxy in $3.2B all-stock deal

Sun Pharma to buy Ranbaxy in $3.2B all-stock deal

TEAM VCC 3 years ago
Sun Pharmaceutical Industries Ltd, the country’s top drugmaker by market cap,...
Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Jyotindra Dubey 3 weeks ago
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20...
Ranbaxy suspends shipment of drugs from two plants

Ranbaxy suspends shipment of drugs from two plants

Lohit Jagwani 4 years ago
Indian drug major Ranbaxy Laboratories Ltd has announced that it has temporarily...
No Comments

Bionpharma acquires 25 products of Banner Life Sciences

Powered by WordPress.com VIP